Efficacy and safety of combination therapy with telmisartan, rosuvastatin, and ezetimibe in patients with dyslipidemia and hypertension: A randomized, double‐blind, multicenter, therapeutic confirmatory, phase III clinical trial
Chan Joo Lee(Yonsei University), Seok‐Min Kang(Harvard University), Jung‐Woo Son(Lodestar Research Corporation (United States)), Il Suk Sohn(Kyung Hee University), Joon‐Hyung Doh(Inje University Ilsan Paik Hospital), Jae‐Hyeong Park(Chungnam National University Hospital), Sang‐Hyun Ihm(The Catholic University of Korea Bucheon St. Mary's Hospital), Jung‐Won Suh(Seoul National University Bundang Hospital), Jinho Shin, Jung Ho Heo(Kosin University), Soon Jun Hong(Yonsei University), Woong Chol Kang(Gachon University), Jong Shin Woo(Kyung Hee University Medical Center), Ju‐Hee Lee(Dongguk University), Jin Won Kim(Korea University Medical Center), Jung Hyun Choi(Pusan National University Hospital), Young Joon Hong(Chonnam National University Hospital), Jae‐Bin Seo(Seoul Metropolitan Government)
Cited by 6
Related Papers
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
|New England Journal of Medicine|2024|693
A New Strategy for Discontinuation of Dual Antiplatelet Therapy
|Journal of the American College of Cardiology|2012|643
Effect of Intravascular Ultrasound–Guided vs Angiography-Guided Everolimus-Eluting Stent Implantation
|JAMA|2015|603
Cryptogenic Stroke and High-Risk Patent Foramen Ovale
|Journal of the American College of Cardiology|2018|570